Clinical Trial Update: Clinical Trial of Sodium Phenylbutyrate in Children With Spinal Muscular Atrophy Types II or III [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 clinical trial evaluating sodium phenylbutyrate in children with spinal muscular atrophy types II and III was terminated, and results were posted in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spinal Muscular Atrophy Type Ii
• Spinal Muscular Atrophy Type Iii

Drugs mentioned

• Sodium phenylbutyrate (sodium phenylbutyrate)

Snippet

Sponsor: Westat | Conditions: Spinal Muscular Atrophy Type II, Spinal Muscular Atrophy Type III | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2010-02-12